← Eichor
Condition: Locoregional Recurrence Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Locoregional Recurrence

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients
Phase 2 · 1 location(s) · Fudan University · NCT06359275Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Phase 1 · 1 location(s) · Beijing Biotech · NCT07480941High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy
Phase N/A · 1 location(s) · Clinica Universidad de Navarra, Universidad de Navarra · NCT06982469Stereotactic Re-irradiation of Local Recurrences of Prostate Cancer After Radiotherapy
Phase 2 · 1 location(s) · Maria Sklodowska-Curie National Research Institute of Oncolo · NCT06201078Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07510815Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squ
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06448026A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Phase 3 · 709 location(s) · AstraZeneca · NCT05774951Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Inte
Phase 3 · 1 location(s) · Fujian Medical University Union Hospital · NCT06441110CRYoablation for Small Tumors As Local Treatment - SIX Trial
Phase 3 · 2 location(s) · Hospital do Coracao · NCT06839001Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
Phase 3 · 16 location(s) · St. Louis University · NCT03295981Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)
Phase 3 · 1 location(s) · Japanese Foundation for Cancer Research · NCT07190443B7-H3 NIR Imaging for Osteosarcoma Surgery
Phase 1/Phase 2 · 1 location(s) · Peking University People's Hospital · NCT06778603uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Phase N/A · 22 location(s) · UroGen Pharma Ltd. · NCT05874921WoW - Single- vs Two-staged Excisions of Thin Melanoma
NA · 1 location(s) · Vastra Gotaland Region · NCT06363591IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma
Phase 3 · 20 location(s) · Ono Pharmaceutical Co., Ltd. · NCT07104032Salvage HDR for Locally Recurrent Prostate Cancer
NA · 1 location(s) · Aarhus University Hospital · NCT04231006Gross Examinations Versus Frozen Section for Assessment of Surgical Margins in Oral Cancers
NA · 3 location(s) · Dr.Pankaj Chaturvedi · NCT04809324The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma
NA · 1 location(s) · Sun Yat-sen University · NCT06609850Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
Phase 3 · 12 location(s) · Sun Yat-sen University · NCT05340491Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
Phase 1 · 1 location(s) · University of Chicago · NCT06912087An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · 798 location(s) · AstraZeneca · NCT05952557Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive
Phase 2 · 21 location(s) · Oana Danciu · NCT05467891Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin
Phase 2 · 1 location(s) · Ayal A. Aizer, MD · NCT07132190Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapy
NA · 3 location(s) · UMC Utrecht · NCT04881487Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in P
Phase 1/Phase 2 · 1 location(s) · Roswell Park Cancer Institute · NCT06307548Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability
NA · 1 location(s) · Institut du Cancer de Montpellier - Val d'Aurelle · NCT06382818Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Can
Phase 2 · 1 location(s) · Shandong Cancer Hospital and Institute · NCT06942416Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence i
Phase 2 · 2 location(s) · michal roll · NCT01898416Intraoperative Rectal Lavage to Prevent Local Recurrence After Laparoscopic Mid-to-Low Rectal Cancer Resection: A Multic
NA · 1 location(s) · Sun Yat-sen University · NCT07512232REPROton-HN: Prospective Observational Study on Proton Re-irradiation for Locoregional Recurrences of Head and Neck Tumo
Phase N/A · 1 location(s) · Istituto Clinico Humanitas · NCT07635641
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.